SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Steffen M, Petersen J, Oldigs M, Karmeier A, Magnussen H, Thiele HG, et al. Increased secretion of tumor necrosis factor-alpha, interleukin-1-beta, and interleukin-6 by alveolar macrophages from patients with sarcoidosis. J Allergy Clin Immunol 1993; 91: 93949.
  • 2
    Bachwich PR, Lynch JP 3rd, Larrick J, Spengler M, Kunkel SL. Tumor necrosis factor production by human sarcoid alveolar macrophages. Am J Pathol 1986; 125: 4215.
  • 3
    Baughman RP, Strohofer SA, Buchsbaum J, Lower EE. Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis. J Lab Clin Med 1990; 115: 3642.
  • 4
    Baughman RP, Iannuzzi M. Tumour necrosis factor in sarcoidosis and its potential for targeted therapy. BioDrugs 2003; 17: 42531.
  • 5
    Muller-Quernheim J. Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Respir J 1998; 12: 71638.
  • 6
    Sweiss NJ, Ellman MH, Curran JJ, Utset T, Park C. TNF-inhibition as novel treatment for refractory sarcoidosis [abstract]. Arthritis Rheum 2001; 44: S121.
  • 7
    Sweiss NJ, Ellman MH, Curran JJ, Park C. TNF-inhibition as novel treatment for refractory sarcoidosis [abstract]. Arthritis Rheum 2002; 46: S324.
  • 8
    Sweiss NJ, Curran J, Ellman M. TNF-inhibition as novel treatment for refractory sarcoidosis [abstract]. Arthritis Rheum 2003; 48: S618.
  • 9
    Sweiss NJ, Utset TO, Curran J, Ellman M. TNF-inhibition as novel therapy for refractory uveitis in Behcet's syndrome and sarcoidosis [abstract]. Arthritis Rheum 2003; 48: S618.
  • 10
    Sweiss NJ, Gundavaram M, Curran JJ, Ellman MH. TNF inhibition as novel therapy for refractory sarcoidosis, long term follow up [abstract]. Arthritis Rheum 2004; 50: S310.
  • 11
    Sweiss NJ, Curran JJ, Ellman MH. TNF- inhibition as novel therapy for refractory inflammatory eye disease in Behcet's syndrome and sarcoidosis [abstract]. Arthritis Rheum 2004; 50: S305.
  • 12
    Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, et al. ATS/ERS/WASOG statement on sarcoidosis: American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 14973.
  • 13
    Baughman RP, Lower EE. Infliximab for refractory sarcoidosis [published erratum appears in Sarcoidosis Vasc Diffuse Lung Dis 2001;18:310]. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 704.
  • 14
    Pritchard C, Nadarajah K. Tumour necrosis factor alpha inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients. Ann Rheum Dis 2004; 63: 31820.
  • 15
    Ulbricht KU, Stoll M, Bierwirth J, Witte T, Schmidt RE. Successful tumor necrosis factor α blockade treatment in therapy-resistant sarcoidosis. Arthritis Rheum 2003; 48: 35423.